Brief: Igc Pharma Inc- Divisional Direction Of Patents, Mexico, Has Issued A Granting Office Action (Goa) For Its Treatment Of Alzheimer's Disease
19/12/2023 14:23
Dec 19 (Reuters) - IGC Pharma Inc IGC.A :
* IGC PHARMA INC- DIVISIONAL DIRECTION OF PATENTS, MEXICO,
HAS
ISSUED A GRANTING OFFICE ACTION (GOA) FOR ITS TREATMENT OF
ALZHEIMER'S DISEASE
Source text for Eikon: ID:nBw2BRMK1a
Further company coverage: IGC.A
((Reuters.Briefs@thomsonreuters.com;))
Recent news on IGC Pharma
See all newsFocus: Companies with cannabis-based drugs eye IPOs, private funding boost after US reclassification
Cannabis stocks climb after Trump signs order to ease curbs on marijuana (updated)
Cannabis stocks rise ahead of potential Trump order to ease marijuana restrictions
Brief: IGC Pharma's Unit Enters Sale Of Assets Agreement For $2.7 Million - SEC Filing
Brief: IGC Pharma Announces Additional Phase 2 Interim Results Highlighting Cognitive Benefits of IGC-AD1 for Alzheimer's Treatment